Chang CC - Search Results

1

A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes.

Peng H, Wen J, Zhang L, Li H, Chang CC, Zu Y, Zhou X. Peng H, et al. Among authors: chang cc. Mol Biosyst. 2012 Apr;8(4):1366-74. doi: 10.1039/c2mb05184b. Epub 2012 Feb 10. Mol Biosyst. 2012. PMID: 22327869

2

Characterization of p38 MAPK isoforms for drug resistance study using systems biology approach.

Peng H, Peng T, Wen J, Engler DA, Matsunami RK, Su J, Zhang L, Chang CC, Zhou X. Peng H, et al. Among authors: chang cc. Bioinformatics. 2014 Jul 1;30(13):1899-907. doi: 10.1093/bioinformatics/btu133. Epub 2014 Mar 10. Bioinformatics. 2014. PMID: 24618474 Free PMC article.

3

P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells.

Wen J, Cheng HY, Feng Y, Rice L, Liu S, Mo A, Huang J, Zu Y, Ballon DJ, Chang CC. Wen J, et al. Among authors: chang cc. Br J Haematol. 2008 Jan;140(2):169-80. doi: 10.1111/j.1365-2141.2007.06895.x. Br J Haematol. 2008. PMID: 18173754 Free article.

4

p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes.

Shahjahan M, Dunphy CH, Ewton A, Zu Y, Monzon FA, Rice L, Chang CC. Shahjahan M, et al. Among authors: chang cc. Am J Clin Pathol. 2008 Oct;130(4):635-41. doi: 10.1309/2450EGK3V0XK8D9D. Am J Clin Pathol. 2008. PMID: 18794058

5

Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic Syndromes.

Beck D, Ayers S, Wen J, Brandl MB, Pham TD, Webb P, Chang CC, Zhou X. Beck D, et al. Among authors: chang cc. BMC Med Genomics. 2011 Feb 23;4:19. doi: 10.1186/1755-8794-4-19. BMC Med Genomics. 2011. PMID: 21342535 Free PMC article.

6

Polymorphisms in TGFbeta and TNFalpha are associated with the myelodysplastic syndrome phenotype.

Powers MP, Nishino H, Luo Y, Raza A, Vanguri A, Rice L, Zu Y, Chang CC. Powers MP, et al. Among authors: chang cc. Arch Pathol Lab Med. 2007 Dec;131(12):1789-93. doi: 10.5858/2007-131-1789-PITATA. Arch Pathol Lab Med. 2007. PMID: 18081437 Free article.

7

p38 Mitogen-activated protein kinase and hematologic malignancies.

Feng Y, Wen J, Chang CC. Feng Y, et al. Among authors: chang cc. Arch Pathol Lab Med. 2009 Nov;133(11):1850-6. doi: 10.5858/133.11.1850. Arch Pathol Lab Med. 2009. PMID: 19886722 Free article. Review.

8

Multiple distinct clones may co-exist in different lineages in myelodysplastic syndromes.

Huang WT, Yang X, Zhou X, Monzon FA, Wen J, Hagenkord JM, Wu LY, Keever-Taylor C, Novoa-Takara L, Wong ST, Young K, Chang CC. Huang WT, et al. Among authors: chang cc. Leuk Res. 2009 Jun;33(6):847-53. doi: 10.1016/j.leukres.2008.10.008. Epub 2008 Dec 11. Leuk Res. 2009. PMID: 19084271

9

Pattern-selection based power analysis and discrimination of low- and high-grade myelodysplastic syndromes study using SNP arrays.

Yang X, Zhou X, Huang WT, Wu L, Monzon FA, Chang CC, Wong ST. Yang X, et al. Among authors: chang cc. PLoS One. 2009;4(4):e5054. doi: 10.1371/journal.pone.0005054. Epub 2009 Apr 8. PLoS One. 2009. PMID: 19352488 Free PMC article.

10

Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.

Wen J, Feng Y, Huang W, Chen H, Liao B, Rice L, Preti HA, Kamble RT, Zu Y, Ballon DJ, Chang CC. Wen J, et al. Among authors: chang cc. Leuk Res. 2010 Jan;34(1):85-92. doi: 10.1016/j.leukres.2009.05.024. Epub 2009 Jul 15. Leuk Res. 2010. PMID: 19608275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,545 results

Search Page

Filters